Stay updated with breaking news from Cheong Boon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
)
Cambridge-based Big Biotech AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio.
(Page 1) AstraZeneca (Cambridge, U.K.) intends to build a $1.5-billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global
British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs.
AstraZeneca plans $1.5 billion ADC manufacturing facility in Singapore, boosting global supply of cancer treatments. Learn more about this greenfield investment.
It is the company's first-ever facility for end-to-end ADC production and is supported by the Singapore EDB.